Home > Insider Trading > Filing (0001209191-17-067259)

Filing Details

Accession Number:: 0001209191-17-067259
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-26 17:30:56
Reporting Period:: 2017-12-22

Accepted Time:: 2017-12-26 17:30:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610853	Helius Medical Technologies Inc.	HSDT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1201810	Dane Andreeff	642 Newtown Yardley Road, Suite 100 Newtown PA 18940		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2017-12-22	141,027	$1.96	1,485,796	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2017-12-22	30,927	$1.96	325,338	No	4	P	Indirect	See footnote
Class A Common Stock	Acquisiton	2017-12-22	83,147	$1.96	789,435	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Warrant (Right to Buy)	Acquisiton	2017-12-22	141,027	$1.96	141,027	$2.45
Class A Common Stock	Warrant (Right to Buy)	Acquisiton	2017-12-22	30,927	$1.96	30,927	$2.45
Class A Common Stock	Warrant (Right to Buy)	Acquisiton	2017-12-22	83,147	$1.96	83,147	$2.45

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
141,027	2020-12-22	No	4	P	Indirect
30,927	2020-12-22	No	4	P	Indirect
83,147	2020-12-22	No	4	P	Indirect

Footnotes

The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.
The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
Immediately exercisable.